ROIV
#518
Roivant Sciences Ltd. - Common Shares
34.5 1 USD
-0.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.06%
Variación mensual
+14.80%
Variación en los últimos 6 meses
+45.24%
Cambio anual
+88.48%
Cierres anteriores
35.9 7
Open
34.5 1
Mínimo
34.5 1
High
34.5 1
Volumen
172
Financials
- Market Capitalization 24.82 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotecnología
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 498 |  MRNA Moderna, Inc. - Common Stock | 67.01 USD | -1.85% | -18.43% | +30.42% | +101.90% | 26.59 B USD | ||
| 515 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.45 USD | +0.04% | -2.40% | +3.60% | +51.50% | 25.10 B USD | ||
| 535 |  INSM Insmed Incorporated - Common Stock | 109.14 USD | -5.60% | -3.60% | +10.53% | -32.65% | 23.66 B USD | ||
| 554 |  INCY Incyte Corporation - Common Stock | 114.23 USD | -2.12% | -2.81% | +5.79% | +63.47% | 22.82 B USD |